Medical imaging startup teams with HP to roll out 3-D tech in clinic

Startup EchoPixel is partnering with tech titan HP to roll out its virtual reality medical imaging system in clinics.

The Mountain View, CA-based company will run its medical imaging tool on HP’s Zvr Interactive Virtual Reality Display and workstation. EchoPixel’s True 3D system creates holographic images that can be viewed in real-time during surgery, a potential boon for doctors.

A partnership with HP is also a "formative moment" for EchoPixel, CEO Ron Schilling said in a statement, as the company looks to put its technology in the hands of more clinicians. 


Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

“HP has a long record of leadership in this industry, a strong network of partnerships, and a powerful commitment to their customers. We believe that Virtual Reality is the next revolution in medical imaging, and with our FDA cleared system, together we can deliver this technology into hospitals, clinics, and medical schools around the world," Schilling said. 

EchoPixel’s system is meant to help surgeons and radiologists, who sometimes struggle to operate or make a diagnosis based on 2-D images. True 3D could improve diagnostic and surgical accuracy and simplify procedures by making it easier for physicians to visualize a patient’s anatomy.

EchoPixel has come a long way since November 2013, when it raised a seed round of almost $4 million. The company is raising Series A funds to fuel operations.

Last year, EchoPixel got FDA clearance for its system. The regulatory signoff laid the foundation for eventual clinical adoption of the technology.

Related Articles:
Startup raising Series A to launch interactive, holographic surgical imaging software
Startup nabs $9M Series A to back 3-D virtual reality brain surgery guidance system


Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.